Vivos Therapeutics Inc. (VVOS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vivos Therapeutics Inc.

    NASDAQ: VVOS · Real-Time Price · USD
    3.19
    -0.01 (-0.31%)
    At close: Oct 03, 2025, 3:59 PM
    3.27
    2.51%
    After-hours: Oct 03, 2025, 07:47 PM EDT

    Vivos Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.93 -1.12 -0.39 -2.35
    PEG Ratio
    		 0.02 0.02 -0.05 0.72
    PS Ratio
    		 1.43 1.10 0.58 2.83
    PB Ratio
    		 2.71 36.91 1.93 1.87
    P/FCF Ratio
    		 -1.62 -1.19 -0.45 -2.63
    P/OCF Ratio
    		 -1.7 -1.27 -0.47 -3.04
    OCF/S Ratio
    		 -0.84 -0.87 -1.22 -0.93
    Debt / Equity Ratio
    		 0.19 4.85 0.50 0.06
    Quick Ratio
    		 1.50 0.34 0.80 3.64
    Current Ratio
    		 1.50 0.34 0.80 3.64
    Asset Turnover
    		 0.98 1.29 1.17 0.50
    Interest Coverage
    		 n/a n/a n/a -1.39K
    Return on Equity
    		 -1.4 -33.05 -4.97 -0.79
    Return on Assets
    		 -0.73 -1.27 -1.74 -0.6
    Return on Invested Capital
    		 -0.99 -3.94 -3.07 -0.71
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.60 0.60 0.63 0.75
    Net Profit Margin
    		 -0.74 -0.98 -1.49 -1.2
    Pretax Profit Margin
    		 -0.74 -0.98 -1.49 -1.2
    Operating Profit Margin
    		 -0.74 -1.25 -1.56 -1.15
    FCF Margin
    		 -0.88 -0.92 -1.28 -1.07
    EBITDA Margin
    		 -0.7 -1.21 -1.52 -1.16

    Add to Watchlist